Gunter Steiner
Overview
Explore the profile of Gunter Steiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steiner G, Toes R
Curr Opin Rheumatol
. 2024 Feb;
36(3):217-224.
PMID: 38411194
Purpose Of Review: RA is characterized by the presence of autoantibodies among which rheumatoid factors (RFs) and antimodified protein antibodies (AMPA) are serological hallmarks of the disease. In recent years,...
2.
Preglej T, Brinkmann M, Steiner G, Aletaha D, Goschl L, Bonelli M
Front Immunol
. 2023 Apr;
14:1096096.
PMID: 37033944
Various autoimmune diseases are characterized by distinct cell subset distributions and activation profiles of peripheral blood mononuclear cells (PBMCs). PBMCs can therefore serve as an ideal biomarker material, which is...
3.
Sieghart D, Konrad C, Swiniarski S, Haslacher H, Aletaha D, Steiner G
Front Immunol
. 2023 Jan;
13:1096866.
PMID: 36685579
Objectives: Anti-citrullinated peptide antibodies (ACPA) are specific markers for rheumatoid arthritis (RA) and typically measured by assays employing a cyclic citrullinated peptide (CCP) as antigen. This study was aimed at...
4.
Trummer M, Galardon E, Mayer B, Steiner G, Stamm T, Kloesch B
Nitric Oxide
. 2022 Oct;
129:41-52.
PMID: 36216240
Hydrogen sulfide (HS) emerged as an essential signaling molecule exerting beneficial effects in various cardiovascular, neurodegenerative, or musculoskeletal diseases with an inflammatory component, such as osteoarthritis. These protective effects were...
5.
Van Hoovels L, Studholme L, Vander Cruyssen B, Sieghart D, Bonroy C, Nagy E, et al.
Ann Rheum Dis
. 2022 Jun;
81(10):1379-1384.
PMID: 35697487
Introduction: Commercial assays measuring antibodies to citrullinated protein/peptide (ACPA) show poor quantitative agreement. The diagnostic industry has never adopted the International Union of Immunological Societies-Centers for Disease Control and Prevention...
6.
Milchram L, Fischer A, Huber J, Soldo R, Sieghart D, Vierlinger K, et al.
Molecules
. 2022 Feb;
27(4).
PMID: 35209238
For the identification of antigenic protein biomarkers for rheumatoid arthritis (RA), we conducted IgG profiling on high density protein microarrays. Plasma IgG of 96 human samples (healthy controls, osteoarthritis, seropositive...
7.
Van Hoovels L, Studenic P, Sieghart D, Steiner G, Bossuyt X, Ronnelid J
J Transl Autoimmun
. 2022 Jan;
5:100142.
PMID: 35036891
Rheumatoid arthritis (RA) is the most common systemic autoimmune disease and also the most severe arthritic disorder. The measurement of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) in serum...
8.
Marklein B, Jenning M, Konthur Z, Haupl T, Welzel F, Nonhoff U, et al.
Arthritis Res Ther
. 2021 Oct;
23(1):255.
PMID: 34627334
No abstract available.
9.
Studenic P, Alunno A, Sieghart D, Bang H, Aletaha D, Bluml S, et al.
Ther Adv Musculoskelet Dis
. 2021 Sep;
13:1759720X211022533.
PMID: 34539818
Aims: To determine the diagnostic value of anti-acetylated peptide antibodies (AAPA) in patients with rheumatoid arthritis (RA). Methods: Three acetylated peptides (ac-lysine, ac-lysine.inv and ac-ornithine) derived from vimentin were employed...
10.
Marklein B, Jenning M, Konthur Z, Haupl T, Welzel F, Nonhoff U, et al.
Arthritis Res Ther
. 2021 Sep;
23(1):239.
PMID: 34521462
Background: There is a need for biomarker to identify patients "at risk" for rheumatoid arthritis (risk-RA) and to better predict the therapeutic response and in this study we tested the...